Diabetes Devices Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

1 RESEARCH SCOPE

1.1 Research Product Definition

1.2 Research Segmentation

1.2.1 Product Type

1.2.2 Main product Type of Major Players

1.3 Demand Overview

1.4 Research Methodology

2 GLOBAL DIABETES DEVICES INDUSTRY

2.1 Summary about Diabetes Devices Industry

2.2 Diabetes Devices Market Trends

2.2.1 Diabetes Devices Production & Consumption Trends

2.2.2 Diabetes Devices Demand Structure Trends

2.3 Diabetes Devices Cost & Price

3 MARKET DYNAMICS

3.1 Manufacturing & Purchasing Behavior in 2020

3.2 Market Development under the Impact of COVID-19

3.2.1 Drivers

3.2.2 Restraints

3.2.3 Opportunity

3.2.4 Risk

4 GLOBAL MARKET SEGMENTATION

4.1 Region Segmentation (2017 to 2021f)

4.1.1 North America (U.S., Canada and Mexico)

4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)

4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)

4.1.4 South America (Brazil,, Argentina, Rest of Latin America)

4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)

4.2 Product Type Segmentation (2017 to 2021f)

4.2.1 Insulin Delivery Devices

4.2.2 Glucose Monitoring Devices

4.2.3 Artificial Pancreas System

4.2.4 Others

4.3 Consumption Segmentation (2017 to 2021f)

4.3.1 Hospital Pharmacies

4.3.2 Retail Pharmacies

4.3.3 Online Pharmacies

4.3.4 Diabetes Clinics/Centers

5 NORTH AMERICA MARKET SEGMENT

5.1 Region Segmentation (2017 to 2021f)

5.1.1 U.S.

5.1.2 Canada

5.1.3 Mexico

5.2 Product Type Segmentation (2017 to 2021f)

5.2.1 Insulin Delivery Devices

5.2.2 Glucose Monitoring Devices

5.2.3 Artificial Pancreas System

5.2.4 Others

5.3 Consumption Segmentation (2017 to 2021f)

5.3.1 Hospital Pharmacies

5.3.2 Retail Pharmacies

5.3.3 Online Pharmacies

5.3.4 Diabetes Clinics/Centers

5.4 Impact of COVID-19 in North America

6 EUROPE MARKET SEGMENTATION

6.1 Region Segmentation (2017 to 2021f)

6.1.1 Germany

6.1.2 UK

6.1.3 France

6.1.4 Italy

6.1.5 Rest of Europe

6.2 Product Type Segmentation (2017 to 2021f)

6.2.1 Insulin Delivery Devices

6.2.2 Glucose Monitoring Devices

6.2.3 Artificial Pancreas System

6.2.4 Others

6.3 Consumption Segmentation (2017 to 2021f)

6.3.1 Hospital Pharmacies

6.3.2 Retail Pharmacies

6.3.3 Online Pharmacies

6.3.4 Diabetes Clinics/Centers

6.4 Impact of COVID-19 in Europe

7 ASIA-PACIFIC MARKET SEGMENTATION

7.1 Region Segmentation (2017 to 2021f)

7.1.1 China

7.1.2 India

7.1.3 Japan

7.1.4 South Korea

7.1.5 Southeast Asia

7.1.6 Australia

7.1.7 Rest of Asia Pacific

7.2 Product Type Segmentation (2017 to 2021f)

7.2.1 Insulin Delivery Devices

7.2.2 Glucose Monitoring Devices

7.2.3 Artificial Pancreas System

7.2.4 Others

7.3 Consumption Segmentation (2017 to 2021f)

7.3.1 Hospital Pharmacies

7.3.2 Retail Pharmacies

7.3.3 Online Pharmacies

7.3.4 Diabetes Clinics/Centers

7.4 Impact of COVID-19 in Europe

8 SOUTH AMERICA MARKET SEGMENTATION

8.1 Region Segmentation (2017 to 2021f)

8.1.1 Brazil

8.1.2 Argentina

8.1.3 Rest of Latin America

8.2 Product Type Segmentation (2017 to 2021f)

8.2.1 Insulin Delivery Devices

8.2.2 Glucose Monitoring Devices

8.2.3 Artificial Pancreas System

8.2.4 Others

8.3 Consumption Segmentation (2017 to 2021f)

8.3.1 Hospital Pharmacies

8.3.2 Retail Pharmacies

8.3.3 Online Pharmacies

8.3.4 Diabetes Clinics/Centers

8.4 Impact of COVID-19 in Europe

9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION

9.1 Region Segmentation (2017 to 2021f)

9.1.1 GCC

9.1.2 North Africa

9.1.3 South Africa

9.1.4 Rest of Middle East and Africa

9.2 Product Type Segmentation (2017 to 2021f)

9.2.1 Insulin Delivery Devices

9.2.2 Glucose Monitoring Devices

9.2.3 Artificial Pancreas System

9.2.4 Others

9.3 Consumption Segmentation (2017 to 2021f)

9.3.1 Hospital Pharmacies

9.3.2 Retail Pharmacies

9.3.3 Online Pharmacies

9.3.4 Diabetes Clinics/Centers

9.4 Impact of COVID-19 in Europe

10 COMPETITION OF MAJOR PLAYERS

10.1 Brief Introduction of Major Players

10.1.1 Medtronic

10.1.2 Sanofi

10.1.3 Novo Nordisk

10.1.4 Eli Lilly and Company

10.1.5 Roche

10.1.6 Medtronic

10.1.7 Baxter

10.1.8 Arkray

10.2 Diabetes Devices Sales Date of Major Players (2017-2020e)

10.2.1 Medtronic

10.2.2 Sanofi

10.2.3 Novo Nordisk

10.2.4 Eli Lilly and Company

10.2.5 Roche

10.2.6 Medtronic

10.2.7 Baxter

10.2.8 Arkray

10.3 Market Distribution of Major Players

10.4 Global Competition Segmentation

11 MARKET FORECAST

11.1 Forecast by Region

11.2 Forecast by Demand

11.3 Environment Forecast

11.3.1 Impact of COVID-19

11.3.2 Geopolitics Overview

11.3.3 Economic Overview of Major Countries

12 REPORT SUMMARY STATEMENT

1.Table Diabetes Devices Product Type Overview

2.Table Diabetes Devices Product Type Market Share List

3.Table Diabetes Devices Product Type of Major Players

4.Table Brief Introduction of Medtronic

5.Table Brief Introduction of Sanofi

6.Table Brief Introduction of Novo Nordisk

7.Table Brief Introduction of Eli Lilly and Company

8.Table Brief Introduction of Roche

9.Table Brief Introduction of Medtronic

10.Table Brief Introduction of Baxter

11.Table Brief Introduction of Arkray

12.Table Products & Services of Medtronic

13.Table Products & Services of Sanofi

14.Table Products & Services of Novo Nordisk

15.Table Products & Services of Eli Lilly and Company

16.Table Products & Services of Roche

17.Table Products & Services of Medtronic

18.Table Products & Services of Baxter

19.Table Products & Services of Arkray

20.Table Market Distribution of Major Players

21.Table Global Major Players Sales Revenue (Million USD) 2017-2020e

22.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e

23.Table Global Diabetes Devices Market Forecast (Million USD) by Region 2021f-2026f

24.Table Global Diabetes Devices Market Forecast (Million USD) Share by Region 2021f-2026f

25.Table Global Diabetes Devices Market Forecast (Million USD) by Demand 2021f-2026f

26.Table Global Diabetes Devices Market Forecast (Million USD) Share by Demand 2021f-2026f